Moderna Scores Huge Grant, Leads Charge Toward Coronavirus Vaccine

With other coronavirus treatments stumbling, this is Moderna’s moment to shine…

This story was originally published here.

The novel coronavirus has wrecked the economy and caused unbelievable chaos for many Americans. While the government is doing its best to mitigate the negative impacts of stay-at-home orders, it’s clear that a bigger solution is needed. Preventative measures such as mask wearing and contact tracing are helpful, but they’re not a solution. To get back to normal, we need a treatment or vaccine. Moderna (NASDAQ:MRNA) stock offers investors one such possibility, as the company is the leading vaccine developer targeting the virus.

The company’s efforts recently earned a high form of validation. The company scored a massive contract with the government to develop the vaccine. In fact, the $483 million the U.S. government gave to Moderna earlier this month may be the most fruitful “bailout” of them all.

After all, the government just wrote a $50 billion check to the U.S. airline industry, and we already know where that money will be going: dollar-bill heaven. Moderna, by contrast, has the potential to spin its handout into gold.

MRNA Stock: A Wise Half-Billion-Dollar Investment

The $483 billion will help Moderna develop and test its promising Covid-19 vaccine. While plenty of biotech companies are racing to formulate a vaccine, most are unproven companies with tiny market capitalizations and little track record of commercial success. It would be great if a smaller player, like Inovio (NASDAQ:INO) or Novavax (NASDAQ:NVAX), comes up with a working vaccine quickly, but they are longer shots at success.

Moderna, by contrast, has a market cap of nearly $20 billion. It’s a well-respected leader in the field. So it’s no accident that the U.S. government chose them as the key partner for a $483 million Biomedical Advanced Research and Development Authority (BARDA) grant to expedite the company’s Covid-19 vaccine development.

Editor's Note: Click here for the full story and to see why Moderna is going to continue to prosper.

#1 5G Stock To Buy Now

There’s a lot of hype surrounding 5G these days…

And for good reason. It’s a breakthrough technology that’s going to change the world and make early investors a fortune.

But investing legend Louis Navellier says there’s only one 5G stock you should be paying attention to right now.

This is coming from the analyst who…

  • Found Microsoft when it was trading for 39 cents.
  • Cisco at 50 cents.
  • Qualcomm at $2.45.
  • Adobe at $1.91.
  • Apple when the legendary software company was trading for $1.38.
  • Amazon when it was just a $46 stock (today it’s over $1,885).

And MarketWatch said he was “the advisor who recommended Google before anyone else.”

Now Louis’s pounding the table on a 5G stock he recently uncovered.

He’s put together a presentation with the full details which you can view right here.